Approved Hospital Formulary
Pharmacy - Home (sharepoint.com) Contact Pharmacy
Show Therapeutic Classes
Legacy Hazardous Drugs Do Not Tube List
QR Code Add Formweb to your mobile device
Android iOS
Approved Hospital Formulary
Pharmacy - Home (sharepoint.com) Contact Pharmacy
Search results for:

eculizumab

eculizumab
Drug Name Form Strength Notes
Soliris SOLUTION, INTRAVENOUS 10 mg/mL
Bkemv SOLUTION, INTRAVENOUS aeeb 10 mg/mL
Epysqli SOLUTION, INTRAVENOUS aagh 10 mg/mL Inpatient Preferred; Formulary with Restrictions
VIEW MORE Complement Inhibitor Agents
Additional Information:

For hospitalized patients, eculizumab is Formulary, Restricted to use for PNH and aHUS indications, with specialist approval.

  • Epysqli® is the preferred product, when eculizumab is used in the hospital

 

The goal of the Ultomiris and Soliris, and the Epysqli REMS programs are to mitigate the risk of serious meningococcal infections, and includes health care provider, patient, health care setting/pharmacy and wholesaler-distributor requirements for dispensing.  See Legacy Health REMS Requirements for detail. 

Last updated: Apr. 28, 2026






This site is intended for the staff of Legacy Health.
While others may view accessible pages, Legacy Health makes no warranty, express or implied,
as to the use of this information outside of Legacy Health.

Copyright © 2026 Rpharmy, LLC ­ All Rights Reserved